InsidersTradesSigma
Explore the complete record of transactions filed by Karin Maria Botha, 首席财务官. Director active across 2 companies, notably Guard Therapeutics International AB (publ). Cumulatively, 2 disclosures have been logged. History available since 3 April 2025. The latest transaction was disclosed on 15 May 2025 (Purchase). Regulator: FIN-FSA. The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条
Karin Maria Botha is the Chief Financial Officer of Guard Therapeutics International AB (publ), a biopharmaceutical company. In her role, she is responsible for financial management and the company's financial strategy. Karin has a strong background in the sector, enabling her to contribute effectively to the growth and sustainability of Guard Therapeutics. Her financial expertise is essential to support the company's strategic objectives.